---
title: "Essa Pharma Inc. — Ownership Dossier"
canonical: https://whiteintel.dev/entity/d7f93430-e102-493c-9adc-42b4e1da5145
json: https://whiteintel.dev/api/public/dossier/d7f93430-e102-493c-9adc-42b4e1da5145
identifier: gb-coh:BC0843022
jurisdiction: GB
risk: Low
source: WhiteIntel corporate-ownership graph
---

# Essa Pharma Inc.

**Type:** Company  
**Jurisdiction:** [GB](https://whiteintel.dev/jurisdictions/gb)  
**Identifier:** `gb-coh:BC0843022`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/d7f93430-e102-493c-9adc-42b4e1da5145  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/d7f93430-e102-493c-9adc-42b4e1da5145  

## Ownership & control

### Holdings / subsidiaries

- **Essa Pharma Inc.** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/6acd9036-2a33-5654-818f-e2e2d681ccf2

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **Essa Pharma Inc.**. Human view: https://whiteintel.dev/entity/d7f93430-e102-493c-9adc-42b4e1da5145 · Structured JSON: https://whiteintel.dev/api/public/dossier/d7f93430-e102-493c-9adc-42b4e1da5145._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._